-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Beyond chronic phase CML: de novo and transformed

Program: Education Program
Session: How Do We Tackle Remaining Clinical Challenges in CML?
Hematology Disease Topics & Pathways:
CML, Chronic Myeloid Malignancies, Diseases, Myeloid Malignancies
Sunday, December 10, 2023, 4:30 PM-5:45 PM

Naranie Shanmuganathan, MBBS, FRACP, FRCPA, PhD

Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia

Disclosures: Shanmuganathan: Takeda: Honoraria; Novartis: Honoraria.

See more of: How Do We Tackle Remaining Clinical Challenges in CML?
See more of: Education Program
Previous Presentation | Next Presentation >>